2017-01-16 人氣:2797[Patent Filing in Taiwan, TJIP Firm] A Settlement of Patent Lawsuit between TWi Pharmaceuticals and Allergan
TWi Pharmaceuticals, Inc. (TWi) announced that it has entered an agreement with Allergan, Inc. that settles the lawsuit filed suit against TWi on July, 2016 regarding TWi’s generic version of Restasis. The agreement provides for the dismissal of all litigation related to TWi’s generic version of Restasis. TWi pointed out that the dismissal of the litigation will permit the US FDA to grant final approval of TWi’s generic product 180 days after the first generic applicant begins commercial marketing of its approved product or sooner if FDA determines that there is no first generic applicant. TWi can thus avoid further litigation cost on its Restasis version launching.